Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... has elapsed between last treatment and enrollment on protocol Eastern Cooperative Oncology Group (ECOG) performance status ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  2. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)

    ... is able to adhere to the study visit schedule and other protocol requirements, including follow-up for response assessments The ...

    Clinical Trial last updated 06/06/2016 - 2:11pm.

  3. Selective Depletion of CD45RA+ Naive T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD

    ... considers that HCT on the high-intensity arms of protocol is contraindicated for that patient the patient may be considered for treatment on the lower intensity arm of the protocol or excluded from the protocol; patients with Gilbert's syndrome and no ...

    Clinical Trial last updated 06/06/2016 - 2:55pm.

  4. Aplastic Anemia Alters Student's Perspective

    ... and that we would follow the “watch and wait” protocol , which lasted for years. There were many difficult days, and ...

    Patient Chronicle last updated 05/10/2016 - 3:33pm.

  5. IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia

    ... must be capable of understanding and complying with protocol requirements, and must be able and willing to sign a written ...

    Clinical Trial last updated 04/29/2016 - 11:05am.

  6. Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

    ... Able to adhere to the study visit schedule and other protocol requirements ...

    Clinical Trial last updated 06/06/2016 - 1:30pm.

  7. Allo HSCT Using RIC for Hematological Diseases

    ... β-2 microglobulin > 3 mg/L, may be considered for this protocol after initial therapy. Myeloproliferative Syndromes ... will be seen by Radiation Oncology prior to entrance on the protocol for approval for additional 200 cGy of TBI. TBI may be delivered by ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  8. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    ... previously will not be allowed unless approved by the Protocol Officer or one of the Protocol Chairs. Patient unable to comply with the treatment protocol ...

    Clinical Trial last updated 06/06/2016 - 1:36pm.

  9. T-cell Depleted Alternative Donor Transplantation

    ... that compromises compliance with the procedures of this protocol , as judged by the principal investigator. ...

    Clinical Trial last updated 04/29/2016 - 3:38pm.

  10. Intra-Osseous Co-Transplant of UCB and hMSC

    ... subjects must be in CNS remission at the time of protocol enrollment if there is a history of CNS involvement Subjects ...

    Clinical Trial last updated 05/02/2016 - 11:15am.